注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
ZyVersa Therapeutics Inc是一家臨床階段的專業生物製藥公司。該公司專註於利用先進技術為腎病或炎癥性疾病患者開發藥物。本公司的開發線包括腎臟候選藥物,即VAR200(2-羥丙基-β-環糊精或 2HPβCD),一種用於治療罕見腎臟疾病、局竈性節段性腎小球硬化的膽固醇外排介質。其VAR 200具有治療其他腎小球疾病的潛力,包括alport綜合征和糖尿病腎病。該公司的開發線還包括抗炎候選藥物,即 IC 100,這是一種正在開發用於治療多種炎癥性疾病的炎性體ASC抑製劑。其2a期腎臟候選產品VAR 200可介導去除導致終末期腎病腎臟損傷的過量細胞內脂質。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Sharon G. Adler | - | - | Member of Scientific Advisory Board |
Stephen C. Glover | 63 | 2022 | Co-Founder, Chairman, CEO & President |
Pablo A. Guzman | 73 | 2023 | Chief Medical Officer, Senior VP of Medical Affairs & Chairman of Renal Scientific Advisory Board |
Min-Chul Park | 41 | 2022 | Independent Director |
Robert W. Keane | - | - | Member of Scientific Advisory Board |
Douglas H. Farrar | 58 | - | Member of Scientific Advisory Board |
Alan C. Herman | 75 | - | Member of Scientific Advisory Board |
William F. Bennett | 74 | - | Member of Scientific Advisory Board |
Robert G. Finizio | 52 | 2022 | Independent Director |
Miguel S. Barbosa | 65 | - | Member of Scientific Advisory Board |
Marlene Haffner | 82 | - | Member of Scientific Advisory Board |
Fernando C. Fervenza | - | - | Member of Renal Scientific Advisory Board |
W. Dalton Dietrich | 70 | - | Member of Scientific Advisory Board |
Daniel G. Baker | - | - | Member of Scientific Advisory Board |
James R. Sapirstein | 62 | 2023 | Independent Director |
Gregory G. Freitag | 61 | 2023 | Independent Director |
Nicholas A. LaBella | 67 | 2022 | Member of Scientific Advisory Board |
Juan Pablo de Rivero Vaccari | - | - | Member of Scientific Advisory Board |
Alessia Fornoni | - | - | Member of Scientific Advisory Board |
Helen Bramlett | - | - | Member of Scientific Advisory Board |
Daniel C. Cattran | - | - | Member of Renal Scientific Advisory Board |
Richard J. Glassock | - | 2023 | Member of Renal Scientific Advisory Board |
Douglas T. Golenbock | - | 2023 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核